Nucleofector™ Basic Parasite Kit 1 and 2

Supplier: LONZA PHARMA - BIOSCIENCE CA

VMI-1011 VMI-1021
CA10064-120EA 1269.93 CAD
CA10064-120 CA10064-606
Nucleofector™ Basic Parasite Kit 1 and 2
Clinical Diagnostic Supplies Clinical Reagents and Kits

The basic parasite Nucleofector® kit 1 is one of our two Nucleofector® kits suited for transfecting parasites, e.g. Plasmodium berghei or Trypanosoma brucei, in Nucleofector® 2b device.


  • Increased transfection efficiencies compared to standard methods, such as electroporation or particle bombardment


Parasitic protozoa infect vertebrates and invertebrates and some are even parasitic in plants. In humans, they can cause severe diseases, such as malaria (Plasmodium), sleeping sickness (Trypanosoma) or leishmaniasis (Leishmania). Nucleofection has proven to provide considerably higher transfection efficiencies (e.g., in Plasmodium berghei and Trypanosoma brucei) compared to standard methods, such as electroporation or particle bombardment. Due to significant genotypic and phenotypic diversity between species and life cycles, we have developed two basic parasite Nucleofector® kits (1 and 2) and an easy-to-use basic parasite Nucleofector® Starter Kit to determine which of the two kits is optimal for a specific parasite type.


The respective cell type-specific optimized protocols or recommendations are available under ‘Instructions’ or in our knowledge database. In these optimized protocols the best Nucleofection conditions are indicated. In addition, we share our experience and knowledge for treatment of individual cell types.


Applications: Proven results for e.g. Plasmodium berghei and Trypanosoma brucei.


Delivery information: Content: 2.25 ml Nucleofector® basic solution for parasites, 0.5 ml supplement 1, 25 aluminum cuvette (100 µl), 25 single use pipettes.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR